News on Dyax from BioPortfolio.com http://www.BioPortfolio.com Consolidated Dyax news from BioPortfolio.com Tue, 09 Feb 2010 21:07:40 GMT en News and FDA Updates for Compugen (NASDAQ:CGEN), Depomed (NASDAQ:DEPO), Dyax (NASDAQ:DYAX)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011401&HITNO=0&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011401&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916508%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4011401&HITNO=0&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4011401&THISHREF=http://c.moreover.com/click/here.pl%3fz2522916508%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Dyax Corp. to Present at the BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998936&HITNO=1&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998936&THISHREF=http://c.moreover.com/click/here.pl%3fz2517264132%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998936&HITNO=1&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998936&THISHREF=http://c.moreover.com/click/here.pl%3fz2517264132%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Dyax Corp. to Present at the BIO CEO & Investor Conferencehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994979&HITNO=2&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994979&THISHREF=http://c.moreover.com/click/here.pl%3fz2515392537%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994979&HITNO=2&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994979&THISHREF=http://c.moreover.com/click/here.pl%3fz2515392537%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: KALBITOR (ecallantide) Now Commercially Availablehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997996&HITNO=3&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997996&THISHREF=http://c.moreover.com/click/here.pl%3fz2516920365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3997996&HITNO=3&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3997996&THISHREF=http://c.moreover.com/click/here.pl%3fz2516920365%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: KALBITOR (ecallantide) Now Commercially Availablehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000541&HITNO=4&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000541&THISHREF=http://c.moreover.com/click/here.pl%3fz2518076534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000541&HITNO=4&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000541&THISHREF=http://c.moreover.com/click/here.pl%3fz2518076534%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: KALBITOR (ecallantide) Now Commercially Availablehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001311&HITNO=5&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001311&THISHREF=http://c.moreover.com/click/here.pl%3fz2518379757%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001311&HITNO=5&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001311&THISHREF=http://c.moreover.com/click/here.pl%3fz2518379757%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Kalbitor (ecallantide) Now Commercially Availablehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998942&HITNO=6&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998942&THISHREF=http://c.moreover.com/click/here.pl%3fz2517267166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998942&HITNO=6&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998942&THISHREF=http://c.moreover.com/click/here.pl%3fz2517267166%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Kalbitor (ecallantide) Now Commercially Availablehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998050&HITNO=7&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998050&THISHREF=http://c.moreover.com/click/here.pl%3fz2516936731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3998050&HITNO=7&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3998050&THISHREF=http://c.moreover.com/click/here.pl%3fz2516936731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Brainloop Invited to Join Massachusetts Biotechnology Council as the First Member Providing an Outlihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993378&HITNO=8&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993378&THISHREF=http://c.moreover.com/click/here.pl%3fz2514566754%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993378&HITNO=8&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993378&THISHREF=http://c.moreover.com/click/here.pl%3fz2514566754%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR-USA.net: Brainloop Invited to Join Massachusetts Biotechnology Council as the First Member Providing an Outlicensing anhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989146&HITNO=9&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989146&THISHREF=http://c.moreover.com/click/here.pl%3fz2512000320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3989146&HITNO=9&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3989146&THISHREF=http://c.moreover.com/click/here.pl%3fz2512000320%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTechWhack: Brainloop Invited to Join Massachusetts Biotechnology Council as the First Memberhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988133&HITNO=10&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988133&THISHREF=http://c.moreover.com/click/here.pl%3fz2510551007%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3988133&HITNO=10&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3988133&THISHREF=http://c.moreover.com/click/here.pl%3fz2510551007%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: FDA approvals of 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960684&HITNO=11&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960684&THISHREF=http://c.moreover.com/click/here.pl%3fz2496367028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960684&HITNO=11&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960684&THISHREF=http://c.moreover.com/click/here.pl%3fz2496367028%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFierceBiotech: FDA actions in brief, January 2010 (Cymbalta, Zyprexa, Zyprexa Relprevv, Intelence, Kalbitor, Istodax, Geodon,http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949378&HITNO=12&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949378&THISHREF=http://c.moreover.com/click/here.pl%3fz2489077203%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3949378&HITNO=12&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3949378&THISHREF=http://c.moreover.com/click/here.pl%3fz2489077203%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFormulary Journal: FDA actions in brief, January 2010 (Cymbalta, Zyprexa, Zyprexa Relprevv, Intelence, Kalbitor, Istodax, Geodon, Vagifem, Seroquel XR, Clonidine ER Suspension, Clonidine ER Tablets, Wilate)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3936016&HITNO=13&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3936016&THISHREF=http://c.moreover.com/click/here.pl%3fz2482812110%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3936016&HITNO=13&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3936016&THISHREF=http://c.moreover.com/click/here.pl%3fz2482812110%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Medicine: Dyax Launches HAE Hope, A New Online Resource For Patients With Hereditary Angioedemahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3918161&HITNO=14&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3918161&THISHREF=http://c.moreover.com/click/here.pl%3fz2472634207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3918161&HITNO=14&MSIZE=24&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Dyax&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3918161&THISHREF=http://c.moreover.com/click/here.pl%3fz2472634207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: